Literature DB >> 11155588

Dapsone and sulfapyridine.

U Paniker1, N Levine.   

Abstract

Dapsone and sulfapyridine are structurally related compounds with anti-microbial and anti-inflammatory effects. Dapsone remains the most important drug for leprosy and is useful in the prophylaxis of Pneumocystis pneumonia in patients with HIV disease. The medical treatment of choice for dermatitis herpetiformis is dapsone; and sulfapyridine also can be used for those patients who are intolerant of dapsone. Other neutrophilic disorders also may respond to these drugs. Toxic side effects of both dapsone and sulfapyridine are mediated through the hydroxylamine metabolite. These include hemolysis, methemoglobinemia, and agranulocytosis. Careful monitoring for possible adverse reactions includes frequently performing complete blood counts and regular blood chemistry profile determinations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11155588     DOI: 10.1016/s0733-8635(05)70231-x

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  7 in total

1.  Celiac sprue: a unique autoimmune disorder.

Authors:  Shadi Rashtak; Eric V Marietta; Joseph A Murray
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

2.  Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris.

Authors:  Diane M Thiboutot; Jonathan Willmer; Harry Sharata; Rebat Halder; Steven Garrett
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation.

Authors:  Vinécius Raphael de Almeida Borges; Alice Simon; Adrian Ricardo Cuello Sena; Lúcio Mendes Cabral; Valéria Pereira de Sousa
Journal:  Int J Nanomedicine       Date:  2013-02-09

4.  The efficacy of 5% dapsone gel plus oral isotretinoin versus oral isotretinoin alone in acne vulgaris: A randomized double-blind study.

Authors:  Gita Faghihi; Mehrdad Rakhshanpour; Bahareh Abtahi-Naeini; Mohammad Ali Nilforoushzadeh
Journal:  Adv Biomed Res       Date:  2014-08-22

Review 5.  The gut microbiome: an orchestrator of xenobiotic metabolism.

Authors:  Stephanie L Collins; Andrew D Patterson
Journal:  Acta Pharm Sin B       Date:  2019-12-10       Impact factor: 11.413

6.  Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness.

Authors:  R E Kast
Journal:  Springerplus       Date:  2015-10-23

7.  Dapsone Azo-Linked with Two Mesalazine Moieties Is a "Me-Better" Alternative to Sulfasalazine.

Authors:  Changyu Kang; Jaejeong Kim; Sanghyun Ju; Sohee Park; Jin-Wook Yoo; In-Soo Yoon; Min-Soo Kim; Yunjin Jung
Journal:  Pharmaceutics       Date:  2022-03-21       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.